What is MOTS-c? A Mitochondrial Peptide Breakdown
Compound Spotlight
MOTS-c overturned a piece of textbook biology. For decades, mitochondrial DNA was understood to encode 13 proteins, all of them components of the respiratory chain. MOTS-c is a peptide encoded inside a mitochondrial gene that was thought to code only for ribosomal RNA — and it acts as a hormone, signaling from the mitochondria to the rest of the cell and even to the nucleus.
Quick summary
- A 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene — not by nuclear DNA.
- Identified in 2015 by Lee, Cohen and colleagues; one of a small class called mitochondrial-derived peptides.
- Acts through the folate-methionine cycle: inhibiting it causes AICAR to accumulate, which activates AMPK.
- Under metabolic stress it translocates into the nucleus and regulates nuclear gene expression — mitochondrial-to-nuclear “retrograde signaling.”
- Circulating levels rise with exercise and decline with age.
- Evidence is preclinical plus human observational genetics. No completed trials of administered MOTS-c in humans.
Why its existence was surprising
Mitochondria carry their own small circular genome, a remnant of their bacterial ancestry. The standard account holds that human mitochondrial DNA encodes 13 proteins, 22 transfer RNAs, and 2 ribosomal RNAs — and that the protein-coding capacity ends there.
MOTS-c is encoded in a short open reading frame located within the 12S ribosomal RNA gene. A sequence long assumed to be purely structural RNA also contains instructions for a functional peptide. Along with humanin, discovered earlier, MOTS-c established the category of mitochondrial-derived peptides and suggested the mitochondrial genome has signaling functions that were simply not being looked for.
The mechanism
MOTS-c does not act on a classical cell-surface receptor. The proposed pathway is indirect and specific: it interferes with the folate-methionine one-carbon cycle, particularly the branch supplying purine biosynthesis. When that branch is inhibited, an intermediate called AICAR accumulates.
AICAR is a well-characterized activator of AMP-activated protein kinase (AMPK) — the cell’s central low-energy sensor. AMPK activation shifts metabolism from storage toward oxidation: increased glucose uptake, increased fatty acid oxidation, suppressed anabolic programs. So MOTS-c reaches a major metabolic switch through a metabolite intermediate rather than by binding a receptor directly, which is an unusual route.
Retrograde signaling
The more striking finding is nuclear translocation. Under metabolic stress, MOTS-c moves into the nucleus and associates with stress-responsive transcription factors, influencing expression of nuclear genes including antioxidant and metabolic programs.
This inverts the usual picture. The nucleus is normally understood to direct the mitochondria; here a mitochondrially encoded peptide travels to the nucleus and helps direct it. That mitochondria might communicate their functional state upward, and adjust nuclear gene expression accordingly, is a genuinely different way of thinking about cellular energy regulation.
Exercise, aging, and human genetics
Circulating MOTS-c increases with exercise in humans, and skeletal muscle appears to be a significant source. This has led to it being described as an exercise-responsive peptide, and to the hypothesis that some metabolic benefits of exercise are partly mediated through mitochondrial-derived peptide signaling. Levels also decline with age.
The most interesting human data is genetic rather than interventional. A specific mitochondrial DNA polymorphism (m.1382A>C) that alters the MOTS-c sequence has been studied in East Asian populations, with reported associations with longevity and with exercise-related phenotypes. This is genuine human evidence that the MOTS-c axis is functionally relevant — but it is observational genetics, which tells you the peptide matters, not what happens if you administer it.
The evidence gap
The interventional evidence is preclinical. In mice, MOTS-c administration has been reported to improve insulin sensitivity, reduce diet-induced obesity, and improve physical capacity in aged animals — promising results in a well-worn model system.
Human interventional data on MOTS-c itself does not exist in published form. A MOTS-c analog (CB4211) was taken into early-phase clinical development by CohBar, but the program did not produce a marketed product and the company subsequently wound down operations. That outcome is not proof the mechanism fails, but it is a meaningful data point about how far the compound has actually travelled toward clinical validation.
Frequently asked questions
What makes MOTS-c different from other peptides here?
It is encoded by mitochondrial DNA rather than nuclear DNA, and within a gene previously thought to code only for ribosomal RNA. Most peptides in this catalog are nuclear-encoded hormones or synthetic analogs of them.
Does MOTS-c work through a receptor?
No classical cell-surface receptor has been identified. The proposed route is metabolic — inhibiting the folate cycle causes AICAR accumulation, which activates AMPK — plus direct nuclear translocation under stress.
Is it the same category as SS-31?
Only in that both concern mitochondria. MOTS-c is a naturally occurring signaling peptide acting on metabolic pathways; SS-31 is a synthetic compound that physically stabilizes the inner mitochondrial membrane.
How do I know what is actually in the vial?
Every lot we sell has a published Certificate of Analysis from an independent, third-party lab confirming identity and purity. Lot numbers on the vial should match the COA you are referencing.
References
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454.
- Kim KH, et al. Mitochondrial peptides modulate mitochondrial function during cellular metabolic stress. Aging. 2018.
- Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12:470.
- Zempo H, et al. A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c. Aging Cell. 2021.
View the MOTS-c product listing →
Read our mitochondrial peptides guide →
Look up your lot Certificate of Analysis →
For laboratory and research use only. Not for human consumption. MOTS-c is not approved by any regulatory authority. This article summarizes published research for informational purposes and is not medical advice, nor a recommendation or protocol for use.
Related research compounds
Arc Peptides supplies these compounds, each third-party tested for purity and identity with a lot-specific Certificate of Analysis:
For laboratory research use only. Not for human consumption.
